- This collaboration gives an built-in resolution for purchasers searching for to outsource the event and manufacturing of microbial and mammalian-expressed peptide medicine, with scalable choices that deal with the total vary of product necessities.
OKLAHOMA CITY & TORRANCE, Calif.–(BUSINESS WIRE)–In response to the rising demand for peptide medicine, Cytovance Biologics and PolyPeptide have introduced a partnership that mixes Cytovance’s experience in microbial and mammalian expression, course of improvement and cGMP manufacturing with PolyPeptide’s capabilities in complicated peptide improvement and manufacturing.
This press launch options multimedia. View the total launch right here: https://www.businesswire.com/information/dwelling/20250113598664/en/
Axel Schleyer, CCO of Cytovance Biologics: Cytovance has been supporting the event and scale-up of microbial and mammalian-expressed biologics for 20 years. Combining our strengths with PolyPeptide’s is precisely what our clients and the business must help the quickly advancing market demand.
Trishul Shah, PolyPeptide Director of Business Improvement: With a monitor document of over 1,000 therapeutic peptides manufactured, PolyPeptide gives deep peptide improvement and synthesis capabilities. The collaboration offers clients entry to complementary know-how portfolios to drive their revolutionary drug improvement tasks.
The 2 corporations have partnered earlier than on particular buyer tasks. The brand new collaboration broadens the partnership to the advantage of drug builders on the lookout for further capability, quick ramp-up, and elevated effectivity, serving to to propel new peptide merchandise to the clinic and the market.
View supply model on businesswire.com: https://www.businesswire.com/information/dwelling/20250113598664/en/
For Cytovance media inquiries, please contact:
[email protected]
@Cytovance Biologics “ observe us on LinkedIn
For PolyPeptide media inquiries, please contact:
[email protected]
@PolyPeptide “ observe us on LinkedIn
Supply: Cytovance Biologics
